Simmons & Simmons JWS advises NSI Ventures and Aviva Ventures on investment into health-tech startup Biofourmis
Simmons & Simmons JWS has advised NSI Ventures and Aviva Ventures on a US$5m Series A investment into Biofourmis Pte. Ltd., a health-tech company based in Singapore.
Biofourmis has developed a sophisticated health analytics platform which utilises artificial intelligence in analysing data to predict a medical patient’s health. If the patient’s health is deteriorating, the platform alerts medical professionals to intervene before a critical event.